Review urges larger trials to learn whether vitamin D deficiency causes rheumatic diseases

A literature review has found that in inflammatory rheumatic diseases, vitamin D deficiency is common and significant, yet there is no strong evidence that the deficit has direct disease-modifying effects. 

Rheumatic diseases involve chronic inflammation and autoimmune responses that often affect the musculoskeletal system, including joints, bones, muscles, tendons, ligaments, and connective tissues.

The research by the International Osteoporosis Foundation (IOF) Osteoimmunology Working Group analyzed various studies, finding that 40% to 80% of patients with inflammatory conditions have insufficient vitamin D. 

The paper connects the deficiency with higher disease activity, fatigue, and poorer musculoskeletal outcomes. Although supplementation corrected the deficiency, resulting in modest benefits for some patients, the researchers stress that these results were inconsistent.

Need for randomized clinical trials

The Osteoporosis International study urges more randomized trials. The paper authors flag that there have been no large, randomized trials and Mendelian randomization studies confirming a causal role of vitamin D in preventing disease or sustaining recovery.

Rheumatic diseases involve chronic inflammation and autoimmune responses that often affect the musculoskeletal system.“Our review underscores the need for better-designed randomized trials to clarify who may benefit most,” says Osvaldo Messina, co-chair of the Osteology Working Group and professor at the IRO Clinical Research and Regenerative Medicine Center in Argentina. 

“There is a need for future large-scale studies that can stratify patients according to baseline vitamin D deficiency and genetic background to better understand the causal mechanisms and the long-term effect of vitamin D repletion in inflammatory rheumatic diseases.”

Meanwhile, a recent study revealed the importance of genes, supplementation, and disease, finding that vitamin D may help delay or prevent the progression of prediabetes, but only in people with certain genetic variations.

Importance of vitamin D

The researchers advise that maintaining serum 25-hydroxyvitamin D concentrations of at least 30 ng/mL is needed for skeletal health. The recommendation aligns with the International Osteoporosis Foundation and other international bodies.

“Vitamin D remains an important component of comprehensive care for patients with inflammatory rheumatic diseases, particularly for bone and muscle health,” comments corresponding author professor Patricia Clark, Faculty of Medicine, National Autonomous University of Mexico. 

“However, despite promising biological mechanisms and observational associations, the current evidence indicates that vitamin D supplementation should not be viewed as a stand-alone disease-modifying therapy.”

The review urges better-designed randomized trials to clarify who may benefit most from vitamin D.To help better understand the role of this vitamin and immunological benefits, the research team outlines unresolved questions. It is not known whether vitamin D deficiency contributes directly to disease mechanisms or only reflects chronic inflammation.

They also suggest future studies find optimal serum vitamin D thresholds for immune modulation alongside the long-term effects and safety of higher-dose supplementation strategies.

Vitamin D in headlines

A previous review supported that personalized exercise programs, improved nutrition, and vitamin D supplements are an effective trifecta approach to prevent falls in aged care homes. 

Another meta-analysis found that vitamin D2 supplements may lower vitamin D3 levels — an essential nutrient for bone and immune health — more than non-supplement users. Researchers recommended prioritizing vitamin D3 supplementation, noting its stronger impact on blood vitamin levels and immune support.